TNS1 expression is significantly elevated in NSCLC tissues and correlates with poor prognosis [47], whereas TNS2 mRNA is significantly downregulated in head and neck, esophageal, breast, lung, liver, and colorectal cancers [13]. This evidence concerns the gene TNS1 and colorectal cancer.